Experimental Hematology
Volume 35, Issue 12 , Pages 1782-1792 , December 2007

MOZ and MOZ-CBP cooperate with NF-κB to activate transcription from NF-κB–dependent promoters

  • Edward M. Chan

      Affiliations

    • Walther Oncology Center, Indianapolis, Ind., USA
    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • Indiana University Cancer Center, Indianapolis, Ind., USA
    • Corresponding Author InformationOffprint request to: Edward M. Chan, M.D., Ely Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285
    • ,
  • Rebecca J. Chan

      Affiliations

    • Department of Pediatrics, Indiana University School of Medicine, Indianpolis, Ind., USA
    • Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianpolis, Ind., USA
    • Indiana University Cancer Center, Indianapolis, Ind., USA
    • Herman B Wells Center for Pediatric Research, Indianapolis, Ind., USA
    • ,
  • Elisha M. Comer

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • ,
  • Robert J. Goulet III

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • ,
  • Colin D. Crean

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • ,
  • Zachary D. Brown

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • ,
  • Amy M. Fruehwald

      Affiliations

    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • ,
  • Zhenyun Yang

      Affiliations

    • Department of Pediatrics, Indiana University School of Medicine, Indianpolis, Ind., USA
    • Herman B Wells Center for Pediatric Research, Indianapolis, Ind., USA
    • ,
  • H. Scott Boswell

      Affiliations

    • Walther Oncology Center, Indianapolis, Ind., USA
    • Department of Medicine, Indiana University School of Medicine, Indianpolis, Ind., USA
    • Indiana University Cancer Center, Indianapolis, Ind., USA
    • ,
  • Harikrishna Nakshatri

      Affiliations

    • Walther Oncology Center, Indianapolis, Ind., USA
    • Department of Surgery at Indiana University School of Medicine, Indianpolis, Ind., USA
    • Indiana University Cancer Center, Indianapolis, Ind., USA
    • ,
  • Theodore G. Gabig

      Affiliations

    • Department of Medicine, State University of New York, Stony Brook, NY, USA

Received 15 December 2006 ,Revised 18 July 2007 ,Accepted 23 July 2007.

References 

  1. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia. N Engl J Med. 1999;341:1051–1062
  2. Huntly BJ, Gilliland DG. Leukaemia stem cells and the evolution of cancer-stem-cell research. Nat Rev Cancer. 2005;5:311–321
  3. Sawyers CL. Molecular genetics of acute leukaemia. Lancet. 1997;349:196–200
  4. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer. 2003;3:89–101
  5. Chan EM, Comer EM, Brown FC, et al. AML1-FOG2 fusion protein in myelodysplasia. Blood. 2005;105:4523–4526
  6. Borrow J, Stanton VP, Andresen JM, et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet. 1996;14:33–41
  7. Crump JG, Swartz ME, Eberhart JK, Kimmel CB. Moz-dependent Hox expression controls segment-specific fate maps of skeletal precursors in the face. Development. 2006;133:2661–2669
  8. Miller CT, Maves L, Kimmel CB. Moz regulates Hox expression and pharyngeal segmental identity in zebrafish. Development. 2004;131:2443–2461
  9. Katsumoto T, Aikawa Y, Iwama A, et al. MOZ is essential for maintenance of hematopoietic stem cells. Genes Dev. 2006;20:1321–1330
  10. Thomas T, Corcoran LM, Gugasyan R, et al. Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. Genes Dev. 2006;20:1175–1186
  11. Kitabayashi I, Aikawa Y, Nguyen LA, Yokoyama A, Ohki M. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein. EMBO J. 2001;20:7184–7196
  12. North T, Gu TL, Stacy T, et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 1999;126:2563–2575
  13. North TE, de Bruijn MF, Stacy T, et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 2002;16:661–672
  14. Kung AL, Rebel VI, Bronson RT, et al. Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. Genes Dev. 2000;14:272–277
  15. Rebel VI, Kung AL, Tanner EA, Yang H, Bronson RT, Livingston DM. Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. Proc Natl Acad Sci U S A. 2002;99:14789–14794
  16. Petrij F, Giles RH, Dauwerse HG, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995;376:348–351
  17. Blobel GA. CREB-binding protein and p300: molecular integrators of hematopoietic transcription. Blood. 2000;95:745–755
  18. Gerritsen ME, Williams AJ, Neish AS, Moore S, Shi Y, Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A. 1997;94:2927–2932
  19. Wadgaonkar R, Phelps KM, Haque Z, Williams AJ, Silverman ES, Collins T. CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling. J Biol Chem. 1999;274:1879–1882
  20. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell. 2002;9:625–636
  21. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell. 1998;1:661–671
  22. Guzman ML, Neering SJ, Upchurch D, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 2001;98:2301–2307
  23. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066–1071
  24. Takahashi S, Harigae H, Ishii KK, et al. Over-expression of Flt3 induces NF-kappaB pathway and increases the expression of IL-6. Leuk Res. 2005;29:893–899
  25. Mukaida N, Mahe Y, Matsushima K. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem. 1990;265:21128–21133
  26. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell. 2004;6:447–458
  27. Boswell HS, Harrington MA, Burgess GS, et al. A mutant RAS gene acts through protein kinase C to augment interleukin-3 dependent proliferation in a fastidious immortal myeloid cell line. Leukemia. 1989;3:662–668
  28. Fukuda S, Pelus LM. Internal tandem duplication of Flt3 modulates chemotaxis and survival of hematopoietic cells by SDF1alpha but negatively regulates marrow homing in vivo. Exp Hematol. 2006;34:1041–1051
  29. Kelly LM, Liu Q, Kutok JL, Williams IR, Boulton CL, Gilliland DG. FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model. Blood. 2002;99:310–318
  30. Holtmann H, Winzen R, Holland P, et al. Induction of interleukin-8 synthesis integrates effects on transcription and mRNA degradation from at least three different cytokine- or stress-activated signal transduction pathways. Mol Cell Biol. 1999;19:6742–6753
  31. McKenna NJ, Nawaz Z, Tsai SY, Tsai MJ, O'Malley BW. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc Natl Acad Sci U S A. 1998;95:11697–11702
  32. Deguchi K, Ayton PM, Carapeti M, et al. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP. Cancer Cell. 2003;3:259–271
  33. Gavaravarapu S, Kamine J. Tip60 inhibits activation of CREB protein by protein kinase A. Biochem Biophys Res Commun. 2000;269:758–766
  34. Huntly BJ, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004;6:587–596
  35. Champagne N, Pelletier N, Yang XJ. The monocytic leukemia zinc finger protein MOZ is a histone acetyltransferase. Oncogene. 2001;20:404–409
  36. Bristow CA, Shore P. Transcriptional regulation of the human MIP-1alpha promoter by RUNX1 and MOZ. Nucleic Acids Res. 2003;31:2735–2744
  37. Pelletier N, Champagne N, Stifani S, Yang XJ. MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2. Oncogene. 2002;21:2729–2740
  38. John S, Howe L, Tafrov ST, Grant PA, Sternglanz R, Workman JL. The something about silencing protein, Sas3, is the catalytic subunit of NuA3, a yTAF(II)30-containing HAT complex that interacts with the Spt16 subunit of the yeast CP (Cdc68/Pob3)-FACT complex. Genes Dev. 2000;14:1196–1208

PII: S0301-472X(07)00437-7

doi: 10.1016/j.exphem.2007.07.015

Experimental Hematology
Volume 35, Issue 12 , Pages 1782-1792 , December 2007

Article Tools

* Image Usage & Resolution